Tuesday brought a wave of fresh analyst coverage, and the sentiment was decidedly optimistic. Four companies attracted new attention from Wall Street research desks, each earning bullish ratings that suggest analysts see meaningful upside ahead.

Clear Street analyst Tim Moore launched coverage on MYR Group Inc. (MYRG) with a Buy rating and set a $295 price target. That's a substantial vote of confidence for the electrical construction company, whose shares closed Monday at $220.51. The target implies roughly 34% upside from current levels, suggesting Moore sees significant room for the stock to run.

Citizens analyst Daniel Stauder initiated coverage on Stereotaxis Inc (STXS) with a Market Outperform rating and a $4 price target. The medical technology company's shares closed at $2.32 on Monday, meaning Stauder's target represents even more dramatic upside potential of approximately 72%. That's the kind of call that gets investors' attention.

Freedom Capital Markets analyst David Silver started coverage on Compass Minerals International, Inc. (CMP) with a Buy rating and a $22 price target. The essential minerals producer closed Monday at $18.53, giving Silver's target about 19% upside from current trading levels.

Finally, HC Wainwright & Co. analyst Joseph Pantginis initiated coverage on ProKidney Corp (PROK) with a Buy rating and announced a $12 price target. ProKidney shares closed at $2.08 on Monday, making this another high-conviction call with substantial upside potential if Pantginis proves correct.

When multiple analysts launch coverage with bullish ratings on the same day, it's worth paying attention. These aren't just minor tweaks to existing coverage, they're fresh perspectives from analysts who've decided these companies are worth following and, more importantly, worth buying.